Register | Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Precision Medicine
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | Upfront Therapy for mRCC
Targeted Therapies introduces Expert Perspective Virtual Tumor Board, a video editorial series featuring multi-disciplinary collaboration between professionals reviewing patient cases and discussing diagnoses, biomarker testing, and treatment strategies.
Browse by Series:
Case 1: Treatment of BRAF-Mutated Colorectal Cancer
Case 1: Treatment of BRAF-Mutated Colorectal Cancer
Case 1: BRAF-Mutated Metastatic Colorectal Cancer
Case 1: BRAF-Mutated Metastatic Colorectal Cancer
Case 4: BCMA-Targeted CAR T-Cell Therapy in Myeloma
Case 4: BCMA-Targeted CAR T-Cell Therapy in Myeloma
Case 4: CAR T-Cell Therapy in Myeloma
Case 4: CAR T-Cell Therapy in Myeloma
Case 4: Molecular Testing and CAR T-Cell Therapy in Myeloma
Case 4: Molecular Testing and CAR T-Cell Therapy in Myeloma
Case 4: CAR T-Cell Therapy for Heavily Pretreated Myeloma
Case 4: CAR T-Cell Therapy for Heavily Pretreated Myeloma
Case 3: Treatment for Relapsed Myeloma with 17p Deletion
Case 3: Treatment for Relapsed Myeloma with 17p Deletion
Case 3: Molecular Testing in Relapsed Myeloma
Case 3: Molecular Testing in Relapsed Myeloma
Case 3: Aggressive Relapse of Multiple Myeloma
Case 3: Aggressive Relapse of Multiple Myeloma
Case 4: Treating EGFR+ NSCLC After Osimertinib
Case 4: Treating EGFR+ NSCLC After Osimertinib
Case 4: Upfront Osimertinib in Metastatic EGFR+ NSCLC
Case 4: Upfront Osimertinib in Metastatic EGFR+ NSCLC
Case 4: EGFR Mutation Analysis Post-Osimertinib
Case 4: EGFR Mutation Analysis Post-Osimertinib
<< Prev Page
Next Page >>
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.